openPR Logo
Press release

Rising Stress and Depression are contributing to the growth of the European Schizophrenia Drugs Market

01-15-2025 03:08 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Research

European Schizophrenia Drugs Market

European Schizophrenia Drugs Market

European schizophrenia drug market is estimated to grow at a CAGR of 1.5%, during the forecast period (2024-2031). The market growth is driven by the increasing number of mental health disorders. Additionally, the government policies in the region for mental health promote market growth. The European schizophrenia drug market is segmented by therapeutic class (second-generation antipsychotics, third-generation antipsychotics, and others) and by treatment (oral and injectables).

Get Free Sample link @ https://www.omrglobal.com/request-sample/european-schizophrenia-drugs-market

Market Dynamics

· The oral segment is anticipated to hold the largest market share during the forecast period, owing to the increase in the prevalence of anxiety and depression.

· The injectable segment is expected to project considerable growth attributed to an increase in R&D for injectable drugs and new product launches.

· The second-generation segment dominated the market, owing to the availability of multiple products and the increasing prevalence of mental disorders.

· The third-generation segment is expected to project considerable growth attributed to the new product approvals and product launches in the segment.

The companies that are contributing to the growth of the European schizophrenia drugs market include Allergan PLC, Otsuka Pharmaceutical Co., Ltd., Eli Lilly and Co., AstraZeneca PLC, and Johnson & Johnson Services, Inc. The market players are contributing significantly to the market growth by the adoption of various strategies including new product launches, mergers and acquisitions, collaborations with the government, funding for start-ups, and technological advancements.

Inquiry Before Buying of European Schizophrenia Drugs Market Report @ https://www.omrglobal.com/inquiry-before-buying/european-schizophrenia-drugs-market

Recent Developments

· In September 2024, Teva Pharmaceuticals presented data informing clinical strategies for switching patients to UZEDY®, at the 37th Annual European College of Neuropsychopharmacology (ECNP) Congress, in Italy. UZEDY® is an extended-release injectable suspension of risperidone for subcutaneous use every one or two months for the treatment of schizophrenia in adults.

· In September 2024, the US Food and Drug Administration (FDA) approved Cobenfy (xanomeline and trospium chloride) for schizophrenia in adults. The first UK trial of the compound is planned in Oxford, in 2025.

· In March 2024, Otsuka Pharmaceutical Co., Ltd announced that the European Commission (EC) has approved Abilify Maintena® 720mg/960mg (aripiprazole). The drug is prescribed as a once-every-two-month Long-Acting Injectable (LAI) formulation for the maintenance treatment of schizophrenia in adult patients stabilized with aripiprazole. The drug is accepted by all European Union (EU) member states, and Iceland, Norway, and Liechtenstein.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Information or Query, Visit @ https://www.omrglobal.com/industry-reports/european-schizophrenia-drugs-market

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising Stress and Depression are contributing to the growth of the European Schizophrenia Drugs Market here

News-ID: 3816401 • Views:

More Releases from Orion Market Research

Road Marking Paint Market : A Guide to Understanding the Process
Road Marking Paint Market : A Guide to Understanding the Process
The Road Marking Paint Market, valued at approximately USD 5.02 billion in 2023, is projected to reach around USD 7.69 billion by 2033, growing at a compound annual growth rate (CAGR) of 4.36% from 2024 to 2033. Road Marking Paint Market Overview The Road Marking Paint Market is steadily expanding, driven by burgeoning infrastructure investments and the need for improved road safety. Governments and municipalities are increasingly allocating funds toward both new
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Outboard Boat Market Size Analysis, Competitive Insights, Leading Players and Gr …
The Outboard Boats Market, valued at approximately USD 5.74 billion in 2023, is projected to grow to around USD 14 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 9% over the 2024-2033 period. Outboard Boat Market Overview The Outboard Boat Market continues to expand robustly, fueled largely by rising demand for recreational boating, favorable economic conditions, and the appeal of leisure marine activities. Innovations in outboard motor technology-including
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Mobile Ticketing Market Size Analysis, Competitive Insights, Leading Players and …
The Mobile Ticketing Market, valued at about USD 2.9 billion in 2023, is anticipated to grow to approximately USD 11.39 billion by 2033, reflecting a robust CAGR of 16.7% from 2024 to 2033. Mobile Ticketing Market Overview The Mobile Ticketing Market is undergoing rapid expansion, driven primarily by the global surge in smartphone usage and consumer preference for contactless, digital experiences. This growth is further propelled by widespread adoption of digital payments,
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Metal Alloy Market Size Analysis, Competitive Insights, Leading Players and Grow …
The Metal Alloy Market, valued at approximately USD 301.7 billion in 2023, is projected to reach USD 533.9 billion by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2033. Metal Alloy Market Overview The Metal Alloy Market is experiencing steady, long-term expansion, driven by growing demand from key sectors such as automotive, aerospace, construction, and electronics. Applications in next-generation vehicles and aircraft are pushing interest in

All 5 Releases


More Releases for European

European Gastroenterology Congress
Peers Alley Media Conferences would like to invite all the outstanding gastroenterologists, gastroenterology surgeons, scientists, academicians, young researchers, business delegates and students from all around the world to attend European Gastroenterology Congress from March 23-24, 2020 in Paris, France. This conference gives an unparalleled opportunity to network with colleagues and learn from the different leaders in gastroenterology research. This conference makes a perfect platform for global networking as it brings together the
23rd European Nephrology Conference
23rd European Nephrology Conference is the world’s leading conference for Nephrology professionals to gather and contribute their research for developing the new techniques in the field of Nephrology. Nephrology Conferences offers over 30 sessions from different areas in the field of Nephrology in the form of Keynote, Plenary and workshop sessions including oral and poster presentations. Nephrology Conferences which is going to be held in global & ancient city Rome, Italy
4th European Biopharma Congress
Biopharmaceuticals Conference Series Conference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria. The opportunity in biopharmaceuticals is big and growing too
18th European Diabetes Congress
It takes us immense pleasure to announce the conference that 18th European Diabetes Congress which is going to be held during July 17-18, 2017 at Lisbon, Portugal. Euro Diabetes 2017 conference will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme, “Diabetes
European Data Portal launched
Luxembourg – The European Commission has launched a quality-assured beta version of the European Data Portal, with more than 240,000 datasets, at the European Data Forum. An international consortium, which is led by Capgemini and of which con terra is a member, is responsible for the implementation. The European Data Portal (www.europeandataportal.eu) enables fast and simple searching of open data from 34 European countries and supports their systematic onward use.
PRISMA European Capacity Platform named Project of the Year at European Gas Conf …
The brand new PRISMA European Capacity Platform, BP’s Vice President for Shah Deniz, Al Cook, and Dr Jonathan Stern of the Oxford Institute for Energy Studies, were honoured at the annual European Gas Conference Awards at the Palais Coburg in Vienna on Wednesday evening. During the awards ceremony, which was attended by leading experts from the European gas industry, PRISMA was named Project of the Year; Al Cook was